Fetal Exploitive Vaccines
In this modern day, abortion has taken on a more aggressive level of depravity with a phenomenon we call “Fetal Exploitation”. This term is not widely used but conveys the concept that after a pre-born human being is murdered in the womb of their mother, certain body tissues and organs are harvested with the purpose of using them in the laboratories of pharmaceutical corporations, food flavoring companies and perfume companies.
Fetal tissues and organs are cleverly renamed when used in the pharmaceutical and food industries and listed in patents and product ingredient lists of vaccines, and in the testing of food flavorings and perfume scents. None of these products would exist apart from participating in the supply and demand chain for aborted baby tissues and organs.
Virtually every pharmaceutical company on the planet practices fetal cell research in one way or the other. It is a commonly held myth that all vaccines are produced from cloned cell cultures derived from a few aborted babies from the 1960s to the 1980s, eliminating the need for a supply of newly aborted babies. This myth is intended to provide self-justification for those who condone and promote these products for the reason that the cloned cells are far removed from the original victim. The truth is that the practice of fetal cell research began almost 90 years ago and was used to produce Polio vaccines in the 1930s. The practice continues to this day as reported by NPR.ORG on April 16,2021 regarding the Biden Administration reversing a former Trump Administration order restricting the practice of fetal cell research. Biden Administration Reverses Trump Fetal Tissue Research Rules : NPR
COVID 19 - Vaccines (2020)
HEK293 cells are used in the testing of the Moderna and Pfizer and included as an ingredient in AstraZeneca. PER.C6 cell lines are included in Johnson and Johnson.
How CAAFE Ministries identifies a company that practices fetal cell exploitation
If any company is involved in the practice of trafficking fetal tissues and organs in any way for any purpose, it will appear in any or all of the following :
(1) Vaccine Product Monograph Sheets,
(2) Pharmaceutical Company's Published Statements, or
(3) Patent Information
1 - Vaccine Product Monograph Sheets
AstraZeneca discloses the use of HEK 293 cells in the production of their Covid vaccine product. Excerpt from page 18 of 27 from AstraZeneca Covid Vaccine Monograph PDF:
Product Characteristics:
AstraZeneca COVID-19 Vaccine is a clear to slightly opaque, colourless to slightly brown, sterile, particle free, pH 6.6, preservative-free, solution for intramuscular injection. One dose (0.5 ml) of AstraZeneca COVID-19 Vaccine contains:
COVID-19 Vaccine (ChAdOx1-S* recombinant) 5 x 1010 viral particles
*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the unmodified SARS-CoV-2 Spike (S) glycoprotein (GP) produced in genetically modified human embryonic kidney (HEK) 293 cells by recombinant DNA technology.
astrazeneca-covid-19-vaccine-pm-en.pdf (canada.ca)
Johnson&Johnson (Janssen) discloses the use of PER.C6 cells in the production of their Covid vaccine product. Excerpt from page 6 of 26 from Janssen Covid Vaccine Monograph PDF:
Janssen COVID-19 Vaccine is a colourless to slightly yellow, clear to very opalescent sterile suspension for intramuscular injection. Janssen COVID-19 Vaccine contains an Adenovirus type 26 (Ad26) vectored COVID-19 vaccine encoding the SARS-CoV-2 Spike (S) protein in a stabilized conformation (replication-incompetent, recombinant) and the non-medicinal ingredients listed in Table 1. The product contains no preservatives. The Adenovirus type 26 (Ad26) vectored COVID-19 vaccine encoding the SARS-CoV-2 Spike (S) protein is produced in the PER.C6® TetR Cell Line and by recombinant DNA technology. janssen-covid-19-vaccine-pm-en.pdf (canada.ca)
2 - Statements Published on Corporate websites that practice fetal cell research
Pfizer Pharmaceuticals website statement regarding use of embryonic tissues in product research:
PFIZER'S STEM CELL RESEARCH POLICYSAVE (Pfizer's Stem Cell Research Policy | pfpfizeruscom)
When people think of human embryonic stem cells, they don't often imagine the power of these cells in drug discovery.
For more than a decade, Pfizer has been using animal or adult stem cells in its laboratories to help screen new compounds and identify safer and more effective medicines.
With compelling evidence from this research, Pfizer has begun to explore accessing drug development technology from leading academic, biotechnology or pharmaceutical partners around the world, who also have experience with currently-available, human embryonic stem cell lines that meet the highest ethical standards set by leading scientific authorities. This Pfizer Stem Cell Policy guides the company's research activities and its exploration of new external partnerships. The policy summary follows:
-
Pfizer recognizes the enormous potential of stem cell research. Stem cells are important tools for modern biomedical research, including Pfizer's search for innovative new medicines.
-
Pfizer has made significant investments in animal stem cells and in human adult hematopoietic (somatic) stem cells. The company will continue to invest in these stem cell technologies.
-
Pfizer recognizes that human embryonic stem cells may provide even greater potential due to their increased ability for self-renewal and capacity to form a wide variety of cells and tissues.
-
Pfizer acknowledges the sensitive issues raised by this research, and we support proper ethical safeguards that take into account both the moral issues and public sensitivities.
-
Pfizer will only engage in stem cell research projects that meet the highest ethical standards set by leading scientific authorities around the world, including the Guidelines developed by the National Academy of Sciences in the USA.
-
Pfizer strongly opposes any efforts to clone human beings.
3 - Patent information
Following the link Google Patents Advanced Search will take you to Google Patents Advanced Search Engine.
For example, type in the search field “Senomyx, HEK”. The results will take you to a list of patents. Select one of the patents and when the page is loaded, open the “Find On Page” function. Type in “Senomyx” and verify that company is listed in the patent. Then type “HEK” in the “Find On Page” function and verify HEK cells are used by that company in their patent.
Senomyx is was a food flavoring company that was later bought out by another food flavoring and perfume company called “Firmenich”. Senomyx was a pioneer in the use of fetal cell cultures used in food flavoring additives. Firmenich continues to use fetal cell research. Firmenich products are used in many consumer food products all over the world. Please see our webpage with a list of “Baby Endangering Products”
See link to the above example and verify for yourself using the “Find On Page” function.
Moderna Pharmaceuticals disclose the use of HEK-293 aborted fetal cell cultures in their vaccine research for "Terminally Modified RNA"
https://patents.google.com/patent/US10925935B2/en?oq=US10925935B2